{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361981470320836480.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1124/jpet.301.2.507"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0022356524356356?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0022356524356356?httpAccept=text/plain"}},{"identifier":{"@type":"URI","@value":"https://syndication.highwire.org/content/doi/10.1124/jpet.301.2.507"}}],"dc:title":[{"@value":"Clinical Pharmacokinetics of 5-Aminolevulinic Acid in Healthy Volunteers and Patients at High Risk for Recurrent Bladder Cancer"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381981470320836352","@type":"Researcher","foaf:name":[{"@value":"James T. Dalton"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470320836485","@type":"Researcher","foaf:name":[{"@value":"Charles R. Yates"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470320836483","@type":"Researcher","foaf:name":[{"@value":"Donghua Yin"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470320836482","@type":"Researcher","foaf:name":[{"@value":"Arthur Straughn"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470320836480","@type":"Researcher","foaf:name":[{"@value":"Stuart L. Marcus"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470320836481","@type":"Researcher","foaf:name":[{"@value":"Allyn L. Golub"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470320836484","@type":"Researcher","foaf:name":[{"@value":"Marvin C. Meyer"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00223565"}],"prism:publicationName":[{"@value":"The Journal of Pharmacology and Experimental Therapeutics"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2002-05","prism:volume":"301","prism:number":"2","prism:startingPage":"507","prism:endingPage":"512"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0022356524356356?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0022356524356356?httpAccept=text/plain"},{"@id":"https://syndication.highwire.org/content/doi/10.1124/jpet.301.2.507"}],"createdAt":"2003-01-10","modifiedAt":"2025-02-19","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050564285813635200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1050854065068748288","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Antiviral activity of 5-aminolevulinic acid against variants of severe acute respiratory syndrome coronavirus 2"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004239492109056","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Detection of Lymph Node Metastases in Human Colorectal Cancer by Using 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence with Spectral Unmixing"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168865127168","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The sustaining of fluorescence in photodynamic diagnosis after the administration of 5-aminolevulinic acid in carcinogen-induced bladder cancer orthotopic rat model and urothelial cancer cell lines"}]},{"@id":"https://cir.nii.ac.jp/crid/1360022305561081088","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283690950829824","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"5-Aminolevulinic acid regulates the inflammatory response and alloimmune reaction"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693634902144","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"5-Aminolevulinic acid combined with ferrous iron induces carbon monoxide generation in mouse kidneys and protects from renal ischemia-reperfusion injury"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567181956188288","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Dynamics of absorption, metabolism, and excretion of 5-aminolevulinic acid in human intestinal Caco-2 cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1361412891555363328","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pharmacological prospects of G-quadruplexes for neurological diseases using porphyrins"}]},{"@id":"https://cir.nii.ac.jp/crid/1390588744673119360","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Risk Factor of Persistent Hypotension Associated with 5-Aminolevulinic Acid: A Single-Institution Retrospective Study"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1124/jpet.301.2.507"},{"@type":"CROSSREF","@value":"10.3390/ijms141123140_references_DOI_JOVQB3ExbntwVcA1TamZGNcH2El"},{"@type":"CROSSREF","@value":"10.1016/j.pdpdt.2021.102309_references_DOI_JOVQB3ExbntwVcA1TamZGNcH2El"},{"@type":"CROSSREF","@value":"10.1101/2020.10.28.355305_references_DOI_JOVQB3ExbntwVcA1TamZGNcH2El"},{"@type":"CROSSREF","@value":"10.1152/ajprenal.00275.2013_references_DOI_JOVQB3ExbntwVcA1TamZGNcH2El"},{"@type":"CROSSREF","@value":"10.1038/s41591-018-0018-6_references_DOI_JOVQB3ExbntwVcA1TamZGNcH2El"},{"@type":"CROSSREF","@value":"10.1016/j.bbrc.2021.01.091_references_DOI_JOVQB3ExbntwVcA1TamZGNcH2El"},{"@type":"CROSSREF","@value":"10.1186/s41182-021-00397-x_references_DOI_JOVQB3ExbntwVcA1TamZGNcH2El"},{"@type":"CROSSREF","@value":"10.1248/bpb.b25-00474_references_DOI_JOVQB3ExbntwVcA1TamZGNcH2El"},{"@type":"CROSSREF","@value":"10.1016/j.intimp.2015.11.034_references_DOI_JOVQB3ExbntwVcA1TamZGNcH2El"},{"@type":"CROSSREF","@value":"10.1016/j.bbrc.2020.01.054_references_DOI_JOVQB3ExbntwVcA1TamZGNcH2El"},{"@type":"CROSSREF","@value":"10.1016/j.bbrep.2017.07.006_references_DOI_JOVQB3ExbntwVcA1TamZGNcH2El"}]}